search icon

    Market Snapshot

    • S&P Futures

      4,132.5

    • Dow Futures

      32,787

    • Nasdaq Futures

      13,101.5

    blog search icon

    Aravive, Inc.

    (NASDAQ:ARAV)

    $1.00

    $0.08

    8.61%

    Aravive, Inc. Chart

    ARAV Stock Price Today

    Aravive, Inc. (ARAV) stock rallied over 8.61% intraday to trade at $1 a share on NASDAQ. The stock opened with a gain of 9.89% at $0.92 and touched an intraday high of $1.06, rising 8.58% against the last close of $0.921. The stock went to a low of $0.92 during the session.

    Stock Snapshot

    $0.921

    Prev. Close

    28.45 Million

    Market Cap

    $0.92

    Day Low

    $0.92

    Open

    21.13 Million

    Number of Shares

    $1.06

    Day High

    -

    P/E ratio

    -2.12

    EPS (TTM)

    2.28

    Cash Flow per Share

    0.95

    Free Float in %

    2.60

    Book Value

    232,887

    Volume

    Aravive, Inc. Historical Data

    DateOpenHighLowCloseVolume
    2022-08-08$0.92$1.06$0.92$1232,887
    2022-08-05$0.91$0.972$0.877$0.92158,100
    2022-08-04$0.85$0.94$0.84$0.9139,900
    2022-08-03$0.824$0.868$0.799$0.86539,500
    2022-08-02$0.817$0.838$0.796$0.821100,400
    2022-08-01$0.871$0.88$0.822$0.8360,100
    2022-07-29$0.836$0.879$0.82$0.87344,300
    2022-07-28$0.85$0.89$0.8$0.82251,700
    2022-07-27$0.882$0.882$0.84$0.84225,600
    2022-07-26$0.86$0.89$0.815$0.84100,100

    Contact Details

    River Oaks Tower
    Suite 1200 3730 Kirby Drive
    Houston, TX 77098
    United States

    Webiste:ARAV

    936 355 1910

    Company Information

    Employees-

    Beta2.39

    Sales or Revenue8.28 Million

    5Y Sales Change-

    Fiscal Year Ends2021-12-30

    SectorHealth Care

    IndustryBiotechnology

    About Company

    Aravive, Inc., a clinical-stage biopharmaceutical company, develops treatments for life-threatening diseases, including cancer and fibrosis in the United States. Its lead product candidate is batiraxcept, an ultrahigh-affinity, decoy protein that targets the GAS6-AXL signaling pathway, which is in Phase III clinical trial for the treatment of platinum- resistant recurrent ovarian cancer; and in Phase Ib/II clinical trial for the treatment of clear cell renal cell carcinoma and pancreatic adenocarcinoma. The company also develops AVB-S6, a soluble Fc-fusion protein to block the activation of the GAS6-AXL signaling pathway. It has a strategic collaboration agreement with WuXi Biologics (Hong Kong) Limited to develop novel high-affinity bispecific antibodies targeting cancer and fibrosis; and license agreement with 3D Medicines Inc. to develop products that contain batiraxcept as the sole drug substance for the treatment of human oncological diseases in mainland China, Taiwan, Hong Kong, and Macau. The company was formerly known as Versartis, Inc. and changed its name to Aravive, Inc. in October 2018. Aravive, Inc. was incorporated in 2008 and is headquartered in Houston, Texas.

    Frequently Asked Questions

    icon

    What is the current Aravive, Inc. (ARAV) stock price?

    Aravive, Inc. (NASDAQ: ARAV) stock price is $1 as of the last check on Monday, August 8. During the trading session, ARAV stock reached the peak price of $1.06 while $0.92 was the lowest point it dropped to.

    icon

    ARAV's industry and sector of operation?

    The NASDAQ listed ARAV is part of Biotechnology industry that operates in the broader Health Care sector. Aravive, Inc. , a clinical-stage biopharmaceutical company, develops treatments for life-threatening diseases, including cancer and fibrosis in the United States.

    icon

    Who are the executives of ARAV?

    Dr. Fredric N. Eshelman Pharm.D.
    Exec. Chairman
    Dr. Gail F. McIntyre CH (ASCP), DABT, Ph.D.
    Pres, CEO & Director
    Dr. Joshua Silverman Ph.D.
    Co-Founder
    Mr. Rudy C. Howard B.A., CPA, CPA
    Chief Financial Officer

    icon

    What is the ARAV stock price today?

    ARAV stock traded closed the last session at $1, which is $0.07930000000000004 or 8.613011838818295% lower than its previous close of $0.921. ARAV's current trading price is 25.69% lower than its 52-week high of $4.4 where as its distance from 52-week low of 0.8% is -77.27%.

    icon

    How many employees does ARAV have?

    Number of ARAV employees currently stands at -. ARAV operates from River Oaks Tower, Suite 1200 3730 Kirby Drive, Houston, TX 77098, United States.

    icon

    Link for ARAV official website?

    Official Webiste of $ARAV is: https://aravive.com

    icon

    How do I contact ARAV?

    ARAV could be contacted at ARAV operates from River Oaks Tower, Suite 1200 3730 Kirby Drive, Houston, TX 77098, United States, or at phone #936 355 1910 and can also be accessed through its website.

    icon

    How many shares of ARAV are traded daily?

    ARAV stock volume for the day was 232,887 shares while in the previous session number of ARAV shares traded was 232,887 . The average number of ARAV shares traded daily for last 3 months was 91.42 Thousands.

    icon

    How much did ARAV change today?

    The percentage change in ARAV stock occurred in the recent session was 8.613011838818295% while the dollar amount for the price change in ARAV stock was $0.07930000000000004.

    icon

    What price range ARAV stock been trading in?

    In the recent session, the day high for ARAV stock was $1.06 while the low for ARAV stock touched on the day was $0.92.

    icon

    What is the market cap of ARAV currently?

    The market value of ARAV currently stands at 28.45 Million with its latest stock price at $1 and 21.13 Million of its shares outstanding.